Stelios Papadopoulos, Director at BG Medicine, Inc. (BGMD), sold 964 shares at $4.01 ($4K) on 2011-11-29, disclosed to the SEC on 2011-12-01.
Open-market sale of $4k BGMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.01 | 14 | $56 | 1.5% |
| 2 | $4.01 | 28 | $112 | 2.9% |
| 3 | $4.01 | 29 | $116 | 3.0% |
| 4 | $4.01 | 37 | $148 | 3.8% |
| 5 | $4.01 | 156 | $626 | 16.2% |
| 6 | $4.01 | 700 |
| $3K |
| 72.6% |
| Total | $4.01 avg | 964 | $4K | 100% |
| Filing → |
| EXEL | SELL | 2024-05-22 | $240K | — | Filing → |
| EXEL | SELL | 2022-02-24 | $3.3M | — | Filing → |
| EXEL | SELL | 2021-05-13 | $911K | — | Filing → |